Terumo (Terumo) Other Gross PPE : $2,705 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Terumo Other Gross PPE?

Terumo's Other Gross PPE for the quarter that ended in Dec. 2023 was $2,705 Mil.

Terumo's quarterly Other Gross PPE declined from Jun. 2023 ($2,753 Mil) to Sep. 2023 ($2,711 Mil) and declined from Sep. 2023 ($2,711 Mil) to Dec. 2023 ($2,705 Mil).

Terumo's annual Other Gross PPE increased from Mar. 2021 ($2,757 Mil) to Mar. 2022 ($2,816 Mil) but then declined from Mar. 2022 ($2,816 Mil) to Mar. 2023 ($2,775 Mil).

Terumo Other Gross PPE Historical Data

The historical data trend for Terumo's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Other Gross PPE Chart

Terumo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Gross PPE

Get a 7-Day Free Trial

1,817.33

2,455.78

2,756.96

2,815.58

2,774.63

Terumo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															2,644.01	2,774.63	2,753.13	2,711.15	2,705.46

Terumo Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Terumo (Terumo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

TRUMF:USA 4543:Japan TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.